Navigation Links
Gut microbiota research: Pinpointing a moving target
Date:2/27/2013

(27 February 2013) Although considerable progress has been made in determining the impact of the gut microbiota on the development of inflammatory bowel disease (IBD) and other gastrointestinal (GI) diseases, the detailed study and understanding of the composition and effects of this intestinal community still faces numerous methodological and empirical challenges.

"Improvement of study design and sample collection, as well as a more precise understanding of the various genetic and environmental influences, are asked for," says Professor Dirk Haller (Technical University Munich, Germany), who addressed some of the central issues that make up the agenda of future research. Further information on this issue one of many topics presented at the 2nd World Summit "Gut Microbiota For Health" in Madrid, Spain, from 24 to 26 February 2013 can be found at http://bit.ly/WED27PR.

To keep themselves up to date on the rapidly increasing advances in the field of gut microbiota research, scientists and health-care professionals came together at the 2nd Gut Microbiota For Health World Summit. This year, the event was hosted by the Gut Microbiota & Health Section of the European Society of Neurogastroenterology and Motility (ESNM) a member of United European Gastroenterology (UEG) and the American Gastroenterological Association (AGA), with the support of Danone Dairy.

A recent overview of gut microbiota research titled "Gut microbiota and gastrointestinal health: current concepts and future directions" has been published in Neurogastroenterology and Motility (Volume 25, Issue 1, pages 415, January 2013), the official journal of the ESNM and the American Neurogastroenterology and Motility Society (ANMS). The article is the first publication of ESNM's Gut Microbiota & Health Section and can be downloaded at http://onlinelibrary.wiley.com/doi/10.1111/nmo.12046/full.


'/>"/>

Contact: Aimee Frank
afrank@gastro.org
301-941-2620
American Gastroenterological Association
Source:Eurekalert

Related medicine news :

1. NIH team describes protective role of skin microbiota
2. Fecal microbiota transplantation cures gastrointestinal diseases
3. Gut microbiota plays important role in functional bowel disorders
4. Breast stem-cell research: Receptor teamwork is required and a new pathway may be involved
5. BioMed Central presents Challenges in Malaria Research: Progress Towards Elimination
6. Research: NCAA football exploits players in invisible labor market
7. Kinsey research: Postpartum women less stressed by threats unrelated to the baby
8. Research: Lupus drugs carry no significant cancer risk for patients
9. Research: Military women may have higher risk for STIs
10. Pinpointing genes that control breast cancer key in finding treatments
11. New surgical technique for removing inoperable tumors of the abdomen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... Elisabete Miranda, ... been honored by Enterprising Women magazine as one of its 2017 Enterprising Women ... business owners. Winners have demonstrated that they have fast-growth businesses, mentor or actively ...
(Date:4/26/2017)... ... April 26, 2017 , ... RawTrition now brings you BioEnergy which is ... from SUPERFOODS! , RawTrition is taking nutrients to the next level! ... body recognizes its raw form (unlike the synthetically made options that are on the ...
(Date:4/26/2017)... , ... April 26, 2017 , ... ... performance, is proud to announce that it has received 510(k) clearance from the ... MyoCycle Home and the MyoCycle Pro. , Both devices are stationary cycling systems ...
(Date:4/25/2017)... , ... April 25, 2017 ... ... in Newport Beach, California, committed to raising awareness for Duchenne muscular dystrophy, ... from its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in ...
(Date:4/25/2017)... ... ... The doctors at Wall Centre Dental are now expanding their practice by accepting ... receive dental care. The doctors offer three treatment options to put victims of ... at their dental office in Vancouver. Wall Centre Dental is currently welcoming even patients ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
(Date:4/20/2017)... 2017 Research and Markets has announced ... Services Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, ... 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing services ... Low drug registration cost in Latin American countries ...
(Date:4/19/2017)... VIEW, Calif. , April 19, 2017  IRIDEX ... it will release financial results for the first quarter ... 3, 2017.  The Company,s management team will host a ... 5:30 p.m. ET. Investors interested in listening ... (844) 707-0665 for domestic callers or (703) 326-3030 for ...
Breaking Medicine Technology: